SPEED研究PPT课件.pptVIP

GUSTO-IV Pilot Trial Rationale for Combination Therapy in AMI Enhance Incidence and Speed of Reperfusion Reduced Mortality Safer Therapy - Less IC bleed Facilitate Early Percutaneous Interventions Rationale for Combination Therapy in AMI Improved Reperfusion Only 40-50% achieve normal perfusion (TIMI grade 3 flow) with fibrinolytic therapy alone Reduced Mortality 30% 1-year mortality among the elderly ( 75 years)in GUSTO-III Rationale for Combination Therapy in AMI Facilitate Early Percutaneous Interventions Improved mortality with primary PCI is limited tohospitals where procedure and exp